Marginal Zone Lymphoma (MZL): Treatment Updates

Listen Now

Topics Covered

• Updates on Marginal Zone Lymphoma (MZL), in the Context of COVID-19 & Its Variants
• Overview of Marginal Zone Lymphoma, including Staging & Location
• Subtypes of Marginal Zone Lymphoma
• Review of Treatment Options
• Treatment for Relapsed/Refractory Marginal Zone Lymphoma
• Managing Treatment Side Effects, Symptoms, Discomfort & Pain
• The Important Role of Clinical Trials
• How Research Contributes to Your Treatment Options
• Communicating with the Health Care Team with Telehealth/Telemedicine Appointments
• Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, List of Questions, Follow-Up Care, Appointments & Discussion of OpenNotes
• Key Questions to Ask Your Health Care Team about Quality-of-Life Concerns
• Questions for Our Panel of Experts

Our Panel of Experts

David J. Straus, MD

Attending Physician, Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Professor of Clinical Medicine, Weill Cornell Medical College

Sarah C. Rutherford, MD

John P. Leonard, MD/Gwirtzman Family Research Scholar in Lymphoma, Assistant Professor of Medicine, Weill Cornell Medical College, Cornell University

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on February 16, 2022.